Tarsus Pharmaceuticals
TARS
TARS
204 hedge funds and large institutions have $1.87B invested in Tarsus Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 87 increasing their positions, 49 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
17% less capital invested
Capital invested by funds: $2.24B → $1.87B (-$369M)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
204
Holding in Top 10
4
Calls
$417K
Puts
–
Top Buyers
| 1 | +$52.4M | |
| 2 | +$25.9M | |
| 3 | +$18M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$14.8M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$13.8M |
Top Sellers
| 1 | -$35.4M | |
| 2 | -$30.9M | |
| 3 | -$18.5M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$13.8M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$13.6M |
